United States: Should Companies Suspend Patent Rights On COVID-19 Vaccines? - Oblon, McClelland, Maier & Neustadt, L.L.P

In early October, Moderna earned praise by announcing that it will not enforce patent rights related to its mRNA coronavirus vaccine during the pandemic.